EDCTP activated its Emergency Funding Mechanism in April 2020 to support collaborative clinical research studies in sub-Saharan Africa to manage and/or prevent the spread of the current COVID-19 outbreak. Twenty-six projects have been supported in 22 countries across sub-Saharan Africa. One year on from the declaration of COVID-19 as a pandemic, many research questions have been answered, many others are still under investigation and new questions are emerging.
Speakers & Participants
Speakers will primarily include representatives of the EDCTP-funded COVID-19 Emergency Projects. Selected speakers will share preliminary findings (where available) and/or lessons learnt so far. The meeting will be open to researchers and all other interested stakeholders.
Agenda
The programme includes presentations and panel discussions on the following topics:
- Surveillance and response
- Focus on special populations (pediatric, pregnant women)
- COVID-19 and other major infectious diseases in sub-Saharan Africa (HIV, TB, Malaria)
- New emerging research questions and knowledge gaps specific to sub-Saharan Africa
When and How to join?
The meeting will be held in 2 separate afternoons via Zoom on 18-19 March 2021, each day from 1 to 5PM Central European Time (CET). Registration is required (one link for both days).
Register in advance for this webinar: https://zoom.us/webinar/register/WN_cHhn2t0SQvuNJYemkJesBg
The Stop
TB Partnership Working Group on New TB Vaccines (WGNV) and the National
Institute for Allergy and Infectious Diseases (NIAID)are
co-hosting a workshop on the topic of Recognition and Control of Mtb
Infected Cells: From Basics to the Clinic. This workshop is intended to address
the need for correlates and to identify platforms that measure recognition or
control of the infected cell - especially in humans - as identified in the EDCTP/AIGHD Global Roadmap for
Research and Development of New TB Vaccines and the Strategic Framework for
New TB Vaccines in the Stop TB Partnership Global Plan to End TB 2023 - 2030.
The overall goals of this workshop
are to:
The workshop format will be largely
discussion-based. Each session will have three short presentations that will
provide a high-level overview of key topics within the session theme, followed
by a discussion between the session chairs, speakers, and participants.
Click here
to view the programme and
speakers.
This workshop is free of charge and
open to any participants interested in this topic.
The International Society for Infectious Diseases (ISID) and the Swiss
Society for Infectious Diseases (SSI) are inviting applications for their joint
Infectious Diseases Research Fellowship Program. The purpose of this programme
is to support infectious disease physicians and scientists from under-resourced
countries through multidisciplinary clinical and laboratory training at a
select biomedical institution in Zurich, Switzerland. The one-year SSI/ISID
Fellowship programme is open to applicants who are 40 years or younger,
citizens and permanent residents of under-resourced countries or Eastern
Europe. The deadline for applications is 16 June 2023.
More information: https://na.eventscloud.com/eSites/748378/Homepage
The MRCT Center and Medable convened a multi-stakeholder task force to address ethical and regulatory opportunities and challenges related to Decentralized Clinical Trials (DCTs). Join them on June 20, from 10 - 11 AM ET, for a joint webinar entitled, "Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices."
During the webinar, Barbara Bierer (MRCT Center), Pam Tenaerts
(Medable) and Leanne Madre (Medable) will present a framework, recommendations,
and tools organized around 3 DCT domains: People, Remote Data Collection, and
Data Oversight. Best practices for the ethical review, approval, and conduct of
DCTs will be provided.
Clinical trial stakeholders (IRB/ECs,
HRPP, sites, sponsors, investigators, and others) to register for the webinar here